GIRK Therapeutics is a pre-clinical stage therapeutics company focused on leveraging and integrating computation, electrophysiology and cortical circuit neurobiology to create the next generation of highly selective molecules for diseases with unmet needs. Harnessing the complexity of ion channels we have built a computational platform that links the binding of allosteric modulators to ion channel function, in-silico.
With this approach we can generate treatments for neuroscience and brain health diseases that have been historically difficult to treat efficaciously.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Boston, Massachusetts 02120, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Neurobiology, Biotechnology, Pharmaceutical Science, Pharmacology, Rare Disease, Electrophysiology, Ion Channels, Neuroscience, CNS, Epilepsy, Computational Models, Drug Discovery, Molecular Dynamics, Psychiatric.
- HQ
- Boston, Massachusetts
Grik Therapeutics Questions
Grik Therapeutics's LinkedIn profile is https://www.linkedin.com/company/grik-therapeutics
Grik Therapeutics has
5 employees.
View email and phone details for 5
employees at Grik Therapeutics.
Grik Therapeutics's industry is
Biotechnology Research
Grik Therapeutics's top competitors are
Caledonia Biotech Consulting,
Lybra Bio,
Tandemai,
Bullseye Biosciences,
Curenfwithjack,
Madrigal Pharmaceuticals,
Stoke Therapeutics,
Synolo Therapeutics,
Black Swann Consulting Group,
Onsero Therapeutics.
Grik Therapeutics's categories are Biotechnology Research
Grik Therapeutics's founding year is 2022
